Assessment of the Effectiveness of a Prototype Diagnostic System of Bacterial Respiratory Infections Based on Real-time Sequencing
1 other identifier
observational
100
1 country
1
Brief Summary
The objective of this project is to test the efficiency of a novel developed protocol for direct real-time metagenomic sequencing of Lower Respiratory Infection samples. The investigators aim to assess the anticipation time, compared to the traditional culturing methods and the accuracy, compared to gold standards
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 9, 2025
CompletedFirst Submitted
Initial submission to the registry
December 2, 2025
CompletedFirst Posted
Study publicly available on registry
December 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedMarch 25, 2026
August 1, 2025
7 months
December 2, 2025
March 24, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
test positivity
assess the effectiveness in detection of positive (Gram+ vs Gram- vs mixed culture samples) vs negative samples
Baseline
species identification
Assess the effectiveness in recognizing the correct bacterial species
Baseline
Secondary Outcomes (1)
anticipation time
Baseline
Eligibility Criteria
Patients tested for Lower Respiratory tract infections using bronchoalveolar lavage samples
You may qualify if:
- Willingness and ability to provide written informed consent prior to performing the study procedures
- Patients older than 18 years of age
- Suspected bacterial Lower Respiratory Infection (LRI)
- µL of lower respiratory tract sample (e.g. Bronchoalveolar lavage) are available after the routine diagnostic procedures are over
You may not qualify if:
- Low amount of leftover specimen
- Complex diagnosis: clinicians could require further analysis after the first diagnosis is produced
- A sample of the same patient has been already included in the study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione IRCCS Policlinico San Matteo di Pavia
Pavia, Pavia, 27100, Italy
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
December 2, 2025
First Posted
December 24, 2025
Study Start
June 9, 2025
Primary Completion
December 31, 2025
Study Completion
May 1, 2026
Last Updated
March 25, 2026
Record last verified: 2025-08